NASDAQ : ENTA

Enanta Pharmaceuticals, Inc.

$13.23 USD

$0.12 (0.92%)

Volume
97.46K
Average Volume
212.6K
Market Capitalization
$307.16M
P/E Ratio
-4.83
Dividend Yield
0.00%
Price Target
$20.00
Year High
$17.15
Year Low
$6.44
Day High
Day Low
Payout Ratio
$0.00
Current Ratio
$3.84

ENTA Estimated and Actual Revenue by Quarter

ENTA Estimated and Actual EPS by Quarter

ENTA Analyst Forecasts

Quarter Date No of Estimates Ebitda Ebit
Low High Average Low High Average
2027-09-30 2 -16.2M -13.23M -14.82M -16.2M -13.23M -14.82M
2027-06-30 2 -17.43M -14.24M -15.95M -17.43M -14.24M -15.95M
2027-03-31 1 -16.59M -13.55M -15.18M -16.59M -13.55M -15.18M
2026-12-31 2 -18.09M -14.78M -16.55M -18.09M -14.78M -16.55M
2026-09-30 3 -16.85M -16.42M -16.64M -16.85M -16.42M -16.64M
2026-06-30 3 -17.38M -16.14M -16.76M -17.38M -16.14M -16.76M
Quarter Date No of Estimates NetIncome SgaExpense
Low High Average Low High Average
2027-09-30 2 -11.75M -9.02M -10.48M 8.09M 9.91M 9.06M
2027-06-30 2 -10.43M -8.01M -9.3M 8.71M 10.66M 9.76M
2027-03-31 1 -10.31M -7.92M -9.19M 8.29M 10.15M 9.29M
2026-12-31 2 -8.75M -6.72M -7.8M 9.04M 11.07M 10.12M
2026-09-30 3 -20.05M -7.52M -13.78M 10.05M 10.31M 10.18M
2026-06-30 3 -15.02M -6.48M -10.89M 9.88M 10.63M 10.25M
Quarter Date No of Revenue Estimates Revenue No of EPS Estimates EPS
Low High Average Low High Average
2027-09-30 2 13.23M 16.2M 14.82M 1 -0.5494 -0.42186 -0.49
2027-06-30 2 14.24M 17.43M 15.95M 1 -0.48773 -0.37451 -0.435
2027-03-31 1 13.55M 16.59M 15.18M 1 -0.48212 -0.37021 -0.43
2026-12-31 2 14.78M 18.09M 16.55M 1 -0.40924 -0.31425 -0.365
2026-09-30 3 16.42M 16.85M 16.64M 3 -0.93776 -0.35166 -0.64471
2026-06-30 3 16.14M 17.38M 16.76M 3 -0.7023 -0.30295 -0.50951